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EVIDENCE BASED NEURO-ONCOLOGY
Timing of postoperative magnetic resonance imaging (MRI) following glioma
resection: Shattering the 72 hour window
Syed Sarmad Bukhari, Muhammad Shahzad Shamim, Fatima Mubarak

Abstract
Extent of enhancing tumour
resection is correlated with
progression free survival
following glioma surgery.
Historically,
a
contrast
enhanced MRI has been
recommended within 72
hours following surgery to
evaluate for residual disease.
This theoretical window was
established amidst conflicting
evidence to avoid reactive
enhancement. Recent studies
with better designs and better
imaging quality have sought
to challenge this window with
a more pragmatic method of
evaluating residual disease.
Keywords: Neuroimaging, Early
postoperative enhancement,
Glioblastoma, Postoperative
MRI.

Figure 1a and 1b: Postoperative 1.5 T MRI (T1WI) axial pre and post-contrast, done within 24 hours of surgery, of a patient who
underwent debulking surgery for a recurrent glioblastoma. In figure 1a, the hyperintense signals in the resection bed are
representative of post-surgical changes. In figure 1b, the single thick white line shows 3.5mm thin linear enhancement especially
at its widest part that is consistent with reactive enhancement. The two thick white lines show enhancement in the residual tumour.

Introduction
Glioblastoma remains the most common primary central
nervous system malignancy with poor outcomes despite
standard of care treatment. The extent of resection of
these tumours dictates prognosis and outcome. This has
been demonstrated by several studies over a period of
many years.1 Several follow up studies have linked
removal of the enhancing part of the tumour with
survival. In cases where total removal is not possible, the
volume of the remaining enhancing tumour is correlated
with survival.2 Further care of these patients is decided
upon post-operative imaging to assess residual disease.
Over time there has been consensus to acquire this
imaging within a 72 hour post-operative window because
after this time there is development of benign contrast
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enhancement that can be confused with residual
disease.3 Herein, the authors review the existing literature
on the optimal timing of post-operative MRI after glioma
surgery.

Review of Evidence
In the late 1970s and early 1980s, the debate of whether
extent of resection influences outcomes in patients with
glioblastomas was raging. Several studies had failed to
demonstrate any improved outcome with more radical
excision versus biopsy. However, several other authors
described improved outcomes following more extensive
resection.4,5 In their recently published perspective piece,
Grasso et al., have described briefly the clear advantage
afforded by gross total resection of the enhancing part of
the tumour when compared with incomplete resection.6
There are now studies also showing a clear benefit of
supramaximal resection of the T2 abnormality area
beyond the enhancing part.7
The current modality of choice for determining extent
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of resection following glioblastoma surgery is MRI with
contrast. The timing of this scan is debated amongst
neurosurgeons and radiologists. The current standard
has been set at <72 hours post-surgery based on early
studies.3 Henegar et al., were the first to describe postoperative MRI changes following non neoplastic brain
parenchyma resection and enhancement patterns that
occur as a result of surgery itself. 8 Ekinci et al.,
published a detailed account of early post-operative
MRI (EPMR) changes following tumour resection in the
first 12-24 hours following surgery.9 They designed this
study to avoid reactive enhancement that had been
shown to develop even prior to 72 hours and described
three patterns of enhancement, thin linear (normal
dural enhancement), thick linear (likely neoplastic)
and thick linear-nodular (likely residual) and examined
their relationship with disease recurrence and
progression.9 Prior to this study it was believed that
there was a 72 hour diagnostic window where all
enhancement was due to residual disease. It was
found that enhancement in some form exists at even
less than 24 hours following surgery however the
pattern of this enhancement was deemed to be
important.9 Lescher et al., demonstrated that patterns
of enhancement are influenced by field strengths as
well. They also showed that nonspecific enhancement
occurs prior to the stipulated 72 hour window and is
also influenced by pre-operative or intra-operative
contrast administration. It was therefore advised to
compare pre-operative and post-operative scans to
identify a residual enhancing tumour.10

Conclusion
Based on the available evidence, we conclude that postoperative imaging in case of glioma surgery should be
acquired as early as possible and any enhancement
observed should be carefully compared with preoperative imaging to delineate true residual disease from
reactive enhancement that is invariably present in the
post-operative environment. MRI done beyond 72 hours
becomes increasingly unreliable. It would also be prudent
to use the same scanner and field strength when
acquiring images.
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